XW0436CIntroduction of Landiolol Antiarrhythmic into Central Vein, Percutaneous Approach, New Technology Group 12

New Technology›Anatomical Regions›Introduction
ICD-10-PCS XW0436C
CMS Source: FY 2027 ICD-10-PCS dataset. Effective Oct 1, 2026 – Sep 30, 2027.FacebookXLinkedInPrint

XW0436C is a billable ICD-10-PCS procedure code for Introduction of Landiolol Antiarrhythmic into Central Vein, Percutaneous Approach, New Technology Group 12. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027). The root operation Introduction involves putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.

Code Identity

ICD-10-PCS Code
XW0436C
Billable Status
Yes — Valid for Submission
Code Describes
Introduction of Landiolol Antiarrhythmic into Central Vein, Percutaneous Approach, New Technology Group 12
Short Description
Introduce Landiolol in Central Vein, Perc, New Tech 12
Parent Code
XW0

PCS Table Breakdown

Each ICD-10-PCS code is built from seven characters, each an axis of the procedure. Hover or tap the icons for the official CMS definitions.

PositionDesignationValueMeaning
1SectionXNew Technology
2Body SystemWAnatomical Regions
3Operation0Introduction
4BodyPart4Central Vein
5Approach3Percutaneous
6Device/Substance/Technology6Landiolol Antiarrhythmic
7QualifierCNew Technology Group 12

In the ICD-10-PCS Alphabetic Index

These FY 2027 ICD-10-PCS Alphabetic Index entries lead to this code:

Iloprost
Leads to this code's table
RAPIBLYK(tm)
Anatomy or device term that leads here
Sarilumab
Leads to this code's table
Posoleucel
Leads to this code's table
Rezafungin
Leads to this code's table
Treosulfan
Leads to this code's table
Baricitinib
Leads to this code's table
Sabizabulin
Leads to this code's table
Tocilizumab
Leads to this code's table
Caplacizumab
Leads to this code's table
COVID-19 Vaccine
Leads to this code's table
Inebilizumab-cdon
Leads to this code's table
Sulbactam-Durlobactam
Leads to this code's table
CD24Fc Immunomodulator
Leads to this code's table
COVID-19 Vaccine Dose 1
Leads to this code's table

Browse the full ICD-10-PCS Alphabetic Index →

Code History

FY 2027New code, effective October 1, 2026.
Replaces previously assigned code(s):
  • 3E043RZ — Introduce of Antiarrhythmic into Central Vein, Perc Approach

Similar Procedure Codes

Questions About XW0436C

Is XW0436C a billable code?

Yes. This is a complete seven-character ICD-10-PCS code, specific enough to report Introduction of Landiolol Antiarrhythmic into Central Vein, Percutaneous Approach, New Technology Group 12 on inpatient claims from October 1, 2026 through September 30, 2027.

What do the characters in XW0436C mean?

The code breaks down character by character: the 1st character X is the Section (New Technology); the 2nd character W is the Body System (Anatomical Regions); the 3rd character 0 is the Operation (Introduction); the 4th character 4 is the BodyPart (Central Vein); the 5th character 3 is the Approach (Percutaneous); the 6th character 6 is the Device/Substance/Technology (Landiolol Antiarrhythmic); the 7th character C is the Qualifier (New Technology Group 12).